Samsung Bio Venture Fund Invests in China’s Phrontline to Deepen Push Into ADC Cancer Therapies

SEOUL, Nov. 25 (Korea Bizwire) — Samsung Group’s bio venture fund will invest in Chinese biotech firm Phrontline Biopharma as part of the group’s broader strategy to expand partnerships in antibody-drug conjugates (ADCs), the group said Tuesday. The investment fund will come from Life Science Fund, created jointly between Samsung Biologics Co., Samsung Bioepis Co. [...]